To examine whether inhibition of Hippo signaling rescues the effect of MT2A on CRC cells, we used XMU-MP-1, a specific inhibitor of MST1/2, to inhibit the phosphorylation of MST1/2. This evidence concerns the gene MST1 and colorectal carcinoma.